Ling Cen

1.9k total citations
44 papers, 1.3k citations indexed

About

Ling Cen is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Ling Cen has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Ling Cen's work include Glioma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (6 papers) and Immune Cell Function and Interaction (5 papers). Ling Cen is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (6 papers) and Immune Cell Function and Interaction (5 papers). Ling Cen collaborates with scholars based in United States, China and Puerto Rico. Ling Cen's co-authors include Jiayuh Lin, Brian Hutzen, Jann N. Sarkaria, Chun‐Liang Chen, Stephanie Deangelis, Brett L. Carlson, Mark A. Schroeder, Sarah Ball, Pui‐Kai Li and Chenglong Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ling Cen

43 papers receiving 1.3k citations

Peers

Countries citing papers authored by Ling Cen

Since Specialization

Citations

This map shows the geographic impact of Ling Cen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Cen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Cen more than expected).

Fields of papers citing papers by Ling Cen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Cen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Cen. The network helps show where Ling Cen may publish in the future.

Co-authorship network of co-authors of Ling Cen

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Cen. A scholar is included among the top collaborators of Ling Cen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Cen. Ling Cen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antitumor CD4+ T Helper 1 Cells Target and Control the Outgrowth of Disseminated Cancer Cells 2025 ·Cancer Immunology Research ·Ganesan Ramamoorthi, Marie Catherine Lee, Carly M. Farrell, Colin Snyder, Seema Garg, Amy L. Aldrich, Vincent Lok, William Dominguez‐Viqueira, (unknown), Marilin Rosa, (unknown), Shari Pilon‐Thomas, Ling Cen, Krithika N. Kodumudi, Doris Wiener, Thórdur Óskarsson, Ana P. Gomes, Robert A. Gatenby, Brian J. Czerniecki	1
2	Pan-cancer γδ TCR analysis uncovers clonotype diversity and prognostic potential 2024 ·Cell Reports Medicine ·Xiaoqing Yu, Li Song, Ling Cen, Biwei Cao, (unknown), Yuanyuan Shen, Daniel Abate‐Daga, Paulo C. Rodrı́guez, José R. Conejo-García, Xuefeng Wang	2
3	Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma 2022 ·Blood ·Michael D. Jain, Bachisio Ziccheddu, Caroline A. Coughlin, Rawan Faramand, Anthony J. Griswold, Kayla Reid, Meghan Menges, Yonghong Zhang, Ling Cen, Xuefeng Wang, Mohammad Hussaini, Ola Landgren, Marco L. Davila, Jonathan H. Schatz, Frederick L. Locke, Francesco Maura	36
4	Fucosylated Proteome Profiling Identifies a Fucosylated, Non-Ribosomal, Stress-Responsive Species of Ribosomal Protein S3 2021 ·Cells ·G. Watson, (unknown), Hui Ren, (unknown), (unknown), David González-Pérez, Lancia Darville, Jiqiang Yao, (unknown), John M. Koomen, Ling Cen, Eric K. Lau	5
5	Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options 2021 ·PLoS ONE ·Jesús González Bosquet, Qing Zhang, William A. Cliby, Jamie N. Bakkum‐Gamez, Ling Cen, Sean C. Dowdy, Mark E. Sherman, S. John Weroha, Amy C. Clayton, Benjamin R. Kipp, Kevin C. Halling, Fergus J. Couch, Karl C. Podratz	8
6	Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells 2021 ·Scientific Reports ·(unknown), (unknown), Tania Mesa, Andrew T. Smith, Ling Cen, Steven A. Eschrich, Guillermo N. Armaiz-Peña, Álvaro N.A. Monteiro	3
7	Noninvasive Assessment of Epidermal Genomic Markers of UV Exposure in Skin 2020 ·Journal of Investigative Dermatology ·(unknown), Nishit Patel, Brittney Sell, (unknown), (unknown), Charles H. Adelmann, Ling Cen, Chia‐Ho Cheng, Jianjun Shen, Christel M. Davis, Erik A. Ehli, Justin Y. Newberg, Basil S. Cherpelis, Michael A. Black, Michael B. Mann, Samir Mitragotri, Kenneth Y. Tsai	6
8	The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss 2020 ·PLoS Genetics ·Bhuvana A. Setty, Goodwin G. Jinesh, Michael Arnold, Fredrik Pettersson, Chia‐Ho Cheng, Ling Cen, Sean Yoder, Jamie K. Teer, Elsa R. Flores, Damon R. Reed, Andrew S. Brohl	25
9	ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression 2019 ·Nature Communications ·Yu Cao, Jimena Trillo-Tinoco, Rosa A. Sierra, Carmen M. Anadon, Wenjie Dai, Eslam Mohamed, Ling Cen, Tara Lee Costich, Anthony M. Magliocco, Douglas C. Marchion, Richard Klar, Sven Michel, Frank Jaschinski, Richard R. Reich, Shikhar Mehrotra, Juan R. Cubillos‐Ruiz, David H. Munn, José R. Conejo-García, Paulo C. Rodrı́guez	111
10	Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression 2019 ·Nature Communications ·Yu Cao, Jimena Trillo-Tinoco, Rosa A. Sierra, Carmen M. Anadon, Wenjie Dai, Eslam Mohamed, Ling Cen, Tara Lee Costich, Anthony Magliocco, Douglas C. Marchion, Richard Klar, Sven Michel, Frank Jaschinski, Richard R. Reich, Shikhar Mehrotra, Juan R. Cubillos‐Ruiz, David H. Munn, José R. Conejo-García, Paulo C. Rodrı́guez	5
11	S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes 2019 ·Leukemia ·Pingyan Cheng, Erika A. Eksioglu, Xianghong Chen, (unknown), Thu Le Trinh, Ling Cen, Jin Qi, David A. Sallman, Yu Zhang, Nhan Tu, William A. Adams, Chunze Zhang, Jinhong Liu, John L. Cleveland, Alan F. List, Wei Sheng	64
12	Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 2018 ·Scientific Reports ·Anxhela Gjyshi, (unknown), Ling Cen, Chia‐Ho Cheng, Chaomei Zhang, (unknown), Jamie K. Teer, Guillermo N. Armaiz-Peña, Álvaro N.A. Monteiro	15
13	[Correlation of cytogenetic changes with VEGF and TRacp-5b levels among 60 elderly patients with multiple myeloma]. 2016 ·PubMed ·Ling Cen, Yu Jiang, Xiuwen Zhang, (unknown), Rong Xiao, (unknown), (unknown), Xuzhang Lu	1
14	Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System 2015 ·Molecular Cancer Therapeutics ·Karen E. Parrish, Ling Cen, J. C. Murray, David Calligaris, Sani H. Kizilbash, Rajendar K. Mittapalli, Brett L. Carlson, Mark A. Schroeder, Julieann Sludden, Alan V. Boddy, Nathalie Y.R. Agar, Nicola J. Curtin, William F. Elmquist, Jann N. Sarkaria	66
15	Delineation ofMGMTHypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma 2015 ·JNCI Journal of the National Cancer Institute ·Shiv K. Gupta, Sani H. Kizilbash, Brett L. Carlson, Ann C. Mladek, Felix Boakye‐Agyeman, Katrina K. Bakken, Jenny L. Pokorny, Mark A. Schroeder, Paul A. Decker, Ling Cen, Jeanette E. Eckel‐Passow, Gobinda Sarkar, Karla V. Ballman, Joel M. Reid, Robert B. Jenkins, Roeland Verhaak, Erik P. Sulman, Gaspar J. Kitange, Jann N. Sarkaria	93
16	Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts 2012 ·Clinical Cancer Research ·Gaspar J. Kitange, Ann C. Mladek, Brett L. Carlson, Mark A. Schroeder, Jenny L. Pokorny, Ling Cen, Paul A. Decker, Wenting Wu, Gwen Lomberk, Shiv K. Gupta, Raúl Urrutia, Jann N. Sarkaria	125
17	P53 deletion is independently associated with increased age and decreased survival in a cohort of Chinese patients with diffuse large B-cell lymphoma 2012 ·Leukemia & lymphoma ·(unknown), Jinyuan He, Ling Cen, (unknown), (unknown), (unknown), Min Zhou	7
18	Human Leukocyte Antigen (HLA)-DRB114 Is Associated with a High Incidence of Acute Lymphocytic Leukemia 2012 ·Onkologie* ·Min Zhou, Hai‐Rong Qiu, Tao Chen, Rong Xiao, (unknown), Ling Cen, Jianyong Li, Kourong Miao	4
19	Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset. 2010 ·PubMed Central ·Mark E. Jentoft, Caterina Giannini, Ling Cen, Bernd W. Scheithauer, (unknown), Jann N. Sarkaria, Patrice C. Abell-Aleff, Erika F. Rodriguez, Ying Li, Fausto J. Rodríguez	22
20	Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma 2007 ·Modern Pathology ·Ling Cen, (unknown), (unknown), (unknown), Stephen J. Qualman, Songlin Yu, Huiyun Xiang, Jiayuh Lin	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact